jump to content jump to footer

Workflow optimization, increased efficiency and reduced errors in clinical trials

"It's a paradigm shift." This is how Prof. Ulf Teichgräber, Director of the Institute of Diagnostic and Interventional Radiology at the University Hospital Jena, describes the improvement in communication with sponsors and CROs through the use of mint Lesion™. Together, Ms. Laura Graziani, study coordinator, Ms. Elisabeth Lammers, study assistant/MTRA, and Prof. Teichgräber describe their journey towards a successful clinical trial center that can now manage up to 40 clinical trials simultaneously.
 
Where results previously had to be painstakingly entered into Excel spreadsheets, mint Lesion™ has taken over the evaluation of all findings since its introduction in 2015, thus increasing the objectivity and validity of the study results.

mint Lesion: lesion categorization under the radiologic recurrence criteria for adjuvant trials
Radiologic recurrence criteria for adjuvant clinical trials in bladder cancer
Radiologic Recurrence Criteria for Adjuvant Clinical Trials in Bladder Cancer
After radical surgery, there is no measurable disease left to follow. A consensus framework defines when a finding on a surveillance scan counts as…
Read more
Radiologist reviewing a glioma MRI case in mint Lesion, with AI-based brain tumor segmentation from Snke (in development)
Consistent Glioma MRI Reporting with mint Lesion
In neuro-oncology, imaging assessments directly shape treatment decisions. For example, under RANO 2.0, whether a follow-up MRI is classified as…
Read more
Portrait of Ralf Heyder, head of the NUM Coordination Office at Charité, interviewed at the RACOON Research Days in Tübingen
Ralf Heyder, head of the NUM Coordination Office at Charité, interviewed at the RACOON Research Days in Tübingen
RACOON in the Network University Medicine – Ralf Heyder on collaborative imaging research
How Germany’s university hospitals built a shared platform for radiological imaging data, and what comes next In early October 2026, representatives…
Read more
scroll-top